Paper33103299
Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling.
Kamali S and 6 others. Brain Pathol, 2021. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling. Papers, record 33103299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33103299
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG35-55 -induced EAE through ERK and Akt signalling.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Encephalomyelitis, Autoimmune, Experimental | Major topic |
| MAP Kinase Signaling System | Major topic |
| Oligodendroglia | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Receptor, Fibroblast Growth Factor, Type 2 | Major topic |
| Animals | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Myelin-Oligodendrocyte Glycoprotein | |
| Peptide Fragments | |
| Spinal Cord |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TEVA Pharma GmbH, Berlin, Germany | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19570828 | Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. | J Immunol | 2009 | https://conductscience.org/library/papers/19570828 | PubMed |
| 2 | 18353554 | Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. | Neurosci Lett | 2008 | https://conductscience.org/library/papers/18353554 | PubMed |
| 3 | 11509953 | Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. | Gene Ther | 2001 | https://conductscience.org/library/papers/11509953 | PubMed |
| 4 | 24259565 | Signaling through ERK1/2 controls myelin thickness during myelin repair in the adult central nervous system. | J Neurosci | 2013 | https://conductscience.org/library/papers/24259565 | PubMed |
| 5 | 22016523 | FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions. | J Neurosci | 2011 | https://conductscience.org/library/papers/22016523 | PubMed |
| 6 | 29512406 | Cytokine signaling in multiple sclerosis: Lost in translation. | Mult Scler | 2018 | https://conductscience.org/library/papers/29512406 | PubMed |
| 7 | 9814819 | Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: temporally distinct expression of midkine and pleiotrophin. | Glia | 1998 | https://conductscience.org/library/papers/9814819 | PubMed |
| 8 | 25589163 | Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination. | Acta Neuropathol Commun | 2014 | https://conductscience.org/library/papers/25589163 | PubMed |
| 9 | 23335751 | Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling. | J Immunol | 2013 | https://conductscience.org/library/papers/23335751 | PubMed |
| 10 | 28914804 | The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28914804 | PubMed |
| 11 | 12145409 | Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. | Dev Neurosci | 2002 | https://conductscience.org/library/papers/12145409 | PubMed |
| 12 | 25913734 | Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions. | Glia | 2015 | https://conductscience.org/library/papers/25913734 | PubMed |
| 13 | 27766432 | Multiple sclerosis: experimental models and reality. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/27766432 | PubMed |
| 14 | 17150206 | Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain. | Dev Biol | 2007 | https://conductscience.org/library/papers/17150206 | PubMed |
| 15 | 16670284 | ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. | J Immunol | 2006 | https://conductscience.org/library/papers/16670284 | PubMed |
| 16 | 25772309 | The Fibroblast Growth Factor signaling pathway. | Wiley Interdiscip Rev Dev Biol | 2015 | https://conductscience.org/library/papers/25772309 | PubMed |
| 17 | 16226508 | The role of erk1 and erk2 in multiple stages of T cell development. | Immunity | 2005 | https://conductscience.org/library/papers/16226508 | PubMed |
| 18 | 21564095 | Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis. | Immunology | 2011 | https://conductscience.org/library/papers/21564095 | PubMed |
| 19 | 20826430 | Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. | Brain | 2010 | https://conductscience.org/library/papers/20826430 | PubMed |
| 20 | 26474658 | Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis. | Neuropharmacology | 2016 | https://conductscience.org/library/papers/26474658 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41751916 | Oligodendrocytes Are Active Participants in the Pathogenesis of Multiple Sclerosis and Its Animal Models. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751916 | PubMed |
| 41488621 | Mechanism analysis and intervention strategies of the inflammatory microenvironment in traumatic spinal cord injury. | Front Immunol | 2025 | https://conductscience.org/library/papers/41488621 | PubMed |
| 40791737 | Therapeutic potential of calcitriol in cerebral ischemia/reperfusion injury: In vivo and in silico insights into TLR4 and FGFR2 pathways. | IBRO Neurosci Rep | 2025 | https://conductscience.org/library/papers/40791737 | PubMed |
| 40571738 | Mutations in the human CSF1R gene impact microglia's maintenance of brain white matter integrity. | Nat Immunol | 2025 | https://conductscience.org/library/papers/40571738 | PubMed |
| 40518115 | FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems. | J Adv Res | 2025 | https://conductscience.org/library/papers/40518115 | PubMed |
| 39635532 | The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. | Front Immunol | 2024 | https://conductscience.org/library/papers/39635532 | PubMed |
| 38638441 | Fibroblast growth factor receptor inhibitors mitigate the neuropathogenicity of Borrelia burgdorferi or its remnants ex vivo. | Front Immunol | 2024 | https://conductscience.org/library/papers/38638441 | PubMed |
| 36924298 | FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/36924298 | PubMed |
| 36643033 | Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2023 | https://conductscience.org/library/papers/36643033 | PubMed |
| 36293040 | Interferon Beta-1a versus Combined Interferon Beta-1a and Oligodendrocyte-Specific FGFR1 Deletion in Experimental Autoimmune Encephalomyelitis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293040 | PubMed |
| 35851701 | Fibroblast growth factor 10 protects against UVB-induced skin injury by activating the ERK/YAP signalling pathway. | Cell Prolif | 2022 | https://conductscience.org/library/papers/35851701 | PubMed |
| 35142107 | New developments in the biology of fibroblast growth factors. | WIREs Mech Dis | 2022 | https://conductscience.org/library/papers/35142107 | PubMed |
| 34691285 | Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant. | Dis Markers | 2021 | https://conductscience.org/library/papers/34691285 | PubMed |
| 34502405 | Oligodendrocyte-Specific Deletion of FGFR1 Reduces Cerebellar Inflammation and Neurodegeneration in MOG35-55-Induced EAE. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502405 | PubMed |
| 34070622 | Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes. | Cells | 2021 | https://conductscience.org/library/papers/34070622 | PubMed |
| 33924474 | FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. | Cells | 2021 | https://conductscience.org/library/papers/33924474 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGF1 | 2246 | PubTator's text mining | https://conductscience.org/library/genes/2246 | NCBI Gene |
| FGF2 | 2247 | PubTator's text mining | https://conductscience.org/library/genes/2247 | NCBI Gene |
| FGF9 | 2254 | PubTator's text mining | https://conductscience.org/library/genes/2254 | NCBI Gene |
| FGFR1 | 2260 | PubTator's text mining | https://conductscience.org/library/genes/2260 | NCBI Gene |
| FGFR2 | 2263 | PubTator's text mining | https://conductscience.org/library/genes/2263 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33103299
GET https://conductscience.org/api/papers/v1/33103299/references?page=2